Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 33 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Procaps Group SA | PROC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.7271 | 11:09:29 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.7271 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 2 | 33 | - | 1.95 - 4.95 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:26:00 | 1 | $ 2.61 | USD |
Procaps Group SA Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 308.01M | 112.82M | - | 409.92M | 42.54M | 0.38 | 7.24 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Procaps News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PROC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.71 | 2.99 | 2.60 | 2.74 | 977 | 0.0171 | 0.63% |
| 1 Month | 3.10 | 3.10 | 2.53 | 2.71 | 3,820 | -0.3729 | -12.03% |
| 3 Months | 3.65 | 3.84 | 2.53 | 3.00 | 12,792 | -0.9229 | -25.28% |
| 6 Months | 2.79 | 4.95 | 2.325 | 3.19 | 30,638 | -0.0629 | -2.25% |
| 1 Year | 4.805 | 4.95 | 1.95 | 3.32 | 19,384 | -2.08 | -43.24% |
| 3 Years | 8.41 | 11.98 | 1.95 | 6.90 | 30,255 | -5.68 | -67.57% |
| 5 Years | 8.41 | 11.98 | 1.95 | 6.90 | 30,255 | -5.68 | -67.57% |
Procaps Description
| Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. It operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs. |
